Detalles de la búsqueda
1.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112687
2.
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
Ann Hematol
; 99(6): 1341-1350, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342134
3.
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival.
Blood
; 127(14): 1828-35, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26903546
4.
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults.
Biol Blood Marrow Transplant
; 22(8): 1473-1479, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118570
5.
[Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)]. / Mise à jour des recommandations pour le choix des unités de sang placentaire en greffe de cellules souches hématopoïétiques (atelier SFGM-TC).
Bull Cancer
; 2024 Mar 13.
Artículo
en Francés
| MEDLINE | ID: mdl-38485627
6.
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft.
Sci Rep
; 10(1): 15399, 2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958816
7.
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide.
Bone Marrow Transplant
; 53(8): 1044-1047, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29391525
Resultados
1 -
7
de 7
1
Próxima >
>>